Hemoglobin News and Research RSS Feed - Hemoglobin News and Research

Philips launches IntelliVue patient monitoring system with Masimo rainbow SET technology

Philips launches IntelliVue patient monitoring system with Masimo rainbow SET technology

As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips today announced the launch of its IntelliVue patient monitoring platform with Masimo rainbow SET technology. [More]
NYU Stern innovation expert uncovers new link between diabetes and Alzheimer's disease

NYU Stern innovation expert uncovers new link between diabetes and Alzheimer's disease

In a new paper published by The Journal of Alzheimer's Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer's disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer's disease. [More]
Person's age, mobility could be powerful predictors of survival than certain biomarkers

Person's age, mobility could be powerful predictors of survival than certain biomarkers

Advances in technology allow scientists to measure intricate details about the human body that greatly enhance understanding of health, disease and aging. [More]
Better management of blood sugar, blood pressure and LDL-cholesterol levels could reduce cardiovascular risk

Better management of blood sugar, blood pressure and LDL-cholesterol levels could reduce cardiovascular risk

While controlling blood pressure, blood sugar and LDL-cholesterol levels reduces the risk of cardiovascular disease in people with diabetes, only 7 percent of diabetic participants in three major heart studies had recommended levels of these three factors, according to research from the Heart Disease Prevention Program at the University of California, Irvine School of Medicine. [More]
People with type 2 diabetes, OSA may not experience improved glycemic control with CPAP

People with type 2 diabetes, OSA may not experience improved glycemic control with CPAP

People with type 2 diabetes and obstructive sleep apnea (OSA) may not experience improved glycemic control by using continuous positive airway pressure, or CPAP, as some studies have suggested, according to the results of a randomized, controlled trial published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. [More]
Novel mechanism identified to protect the brain from many neurodegenerative conditions

Novel mechanism identified to protect the brain from many neurodegenerative conditions

Scientists at Case Western Reserve University School of Medicine have identified a novel mechanism that could be used to protect the brain from damage due to stroke and a variety of neurodegenerative conditions, including sporadic Creutzfeldt-Jakob disease, Alzheimer's disease, and Parkinson's disease. [More]
RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

The U.S. Food and Drug Administration has approved IMBRUVICA (ibrutinib) capsules for treatment-naïve patients with chronic lymphocytic leukemia (CLL). [More]
CPAP appears to improve glycemic control in patients with OSA and type 2 diabetes

CPAP appears to improve glycemic control in patients with OSA and type 2 diabetes

Continuous positive airway pressure, or CPAP, appears to improve glycemic control in patients with obstructive sleep apnea and type 2 diabetes that is not well controlled, according to research published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. [More]
Severe anemia associated with increased risk for necrotizing enterocolitis in premature infants

Severe anemia associated with increased risk for necrotizing enterocolitis in premature infants

A study from Emory University School of Medicine published in the Journal of the American Medical Association has found that severe anemia, but not red blood cell transfusions (RBC), is associated with an increased risk for a potentially fatal intestinal condition in premature infants. [More]
Drug combination improves glucose control in Type 2 diabetes patients

Drug combination improves glucose control in Type 2 diabetes patients

A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss. [More]
Changes in use of anemia drugs affects risk of death or cardiovascular events in dialysis patients

Changes in use of anemia drugs affects risk of death or cardiovascular events in dialysis patients

A new study examines whether recent changes in the use of anemia drugs for patients on dialysis have contributed to changes in rates of death or cardiovascular events. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, indicate that these risks appear to be decreasing for patients on dialysis as well as for older adults (Medicare beneficiaries) who are not on dialysis. [More]
Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Rigel Pharmaceuticals Inc. today announced that it has initiated a Phase 2 clinical trial to evaluate fostamatinib, its oral SYK inhibitor, as a potential treatment for autoimmune hemolytic anemia (AIHA). [More]
Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015. [More]
AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. [More]
New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

EKF Diagnostics, the global in vitro diagnostics company, will be highlighting its new Altair™ 240 clinical chemistry analyzer alongside many of its other point-of-care (POC) and laboratory diagnostics products at Arab Health 2016, Dubai, 25 - 28th January. [More]
Coordinated care approach to diabetes self-management benefits underserved adult populations

Coordinated care approach to diabetes self-management benefits underserved adult populations

Even in communities with barriers to health care, exercise opportunities and healthy food, residents with diabetes saw improved health outcomes when they participated in programs that took a coordinated care approach to diabetes self-management. [More]
“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, “Anemia and hemoglobin testing” . [More]
Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

Bayer announced today that new research findings on Xofigo (radium Ra 223 dichloride) injection will be presented at the 2016 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU) taking place January 7 – 9 in San Francisco. [More]
UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

UAB study to examine social support, intuitive eating impact on older African-American men with diabetes

University of Alabama at Birmingham School of Nursing Assistant Professor Loretta T. Lee, Ph.D., has received a 2015 Deep South Resource Center for Minority Aging pilot grant award to examine the association of social support and intuitive eating with glycemic control in older African-American men with diagnosed type 2 diabetes. [More]
Anemia associated with increased risk of mild cognitive impairment

Anemia associated with increased risk of mild cognitive impairment

In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin <13 g/dl in men and <12 g/dl in women, showed lower performances in verbal memory and executive functions. [More]
Advertisement
Advertisement